Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial

Medicine and Dentistry

• Patient 100%
• Survival 100%
• Hepatic Encephalopathy 75%
• Acute on Chronic Liver Failure 75%
• Serum 50%
• Liver Disease 50%
• Bilirubin 50%
• Liver Dialysis 50%
• Creatinine 25%
• Adverse Event 25%
• Combination Therapy 25%
• Cause of Death 25%
• Predictor 25%
• Extracorporeal 25%
• Odds Ratio 25%
• Liver Cirrhosis 25%
• Spontaneous Bacterial Peritonitis 25%
• Analysis 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Survival 100%
• Hepatic Encephalopathy 75%
• Acute on Chronic Liver Failure 75%
• Liver Disease 50%
• Bilirubin 50%
• Adverse Event 25%
• Cause of Death 25%
• Creatinine 25%
• Confounder 25%
• Liver Cirrhosis 25%
• Bacterial Peritonitis 25%
• Death 25%